{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T06:14:43Z","timestamp":1771654483163,"version":"3.50.1"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T00:00:00Z","timestamp":1755561600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004006","name":"Bilimsel Ara\u015ftirma Projeleri Birimi, Istanbul \u00dcniversitesi","doi-asserted-by":"publisher","award":["TSA-2021-37919"],"award-info":[{"award-number":["TSA-2021-37919"]}],"id":[{"id":"10.13039\/501100004006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"DOI":"10.1007\/s40618-025-02668-4","type":"journal-article","created":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T09:19:10Z","timestamp":1755595150000},"page":"2683-2694","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Leukocytosis may be an indicator of replacement with supraphysiological dose in adrenal insufficiency: relationship with comorbidities and impaired muscle strength"],"prefix":"10.1007","volume":"48","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5259-7326","authenticated-orcid":false,"given":"Ummu","family":"Mutlu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8310-8775","authenticated-orcid":false,"given":"Nubar","family":"Rasulova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9989-6473","authenticated-orcid":false,"given":"Hulya","family":"Hacisahinogullari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9013-5237","authenticated-orcid":false,"given":"Gulsah","family":"Yenidunya Yalin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1187-944X","authenticated-orcid":false,"given":"Nurdan","family":"Gul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0478-1193","authenticated-orcid":false,"given":"Ayse","family":"Kubat Uzum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0732-4764","authenticated-orcid":false,"given":"Ozlem","family":"Soyluk Selcukbiricik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,8,19]]},"reference":[{"issue":"1","key":"2668_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1177\/003591575004300105","volume":"43","author":"PM Bishop","year":"1950","unstructured":"Bishop PM (1950) The history of the discovery of addison\u2019s disease. Proc R Soc Med 43(1):35\u201342. https:\/\/doi.org\/10.1177\/003591575004300105","journal-title":"Proc R Soc Med"},{"issue":"1","key":"2668_CR2","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1210\/jc.2015-3250","volume":"101","author":"T Guran","year":"2016","unstructured":"Guran T, Buonocore F, Saka N et al (2016) Rare causes of primary adrenal insufficiency: genetic and clinical characterization of a large nationwide cohort. J Clin Endocrinol Metab 101(1):284\u2013292. https:\/\/doi.org\/10.1210\/jc.2015-3250","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"2668_CR3","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1007\/s40618-019-01079-6","volume":"42","author":"C Betterle","year":"2019","unstructured":"Betterle C, Presotto F, Furmaniak J (2019) Epidemiology, pathogenesis, and diagnosis of addison\u2019s disease in adults. J Endocrinol Invest 42(12):1407\u20131433. https:\/\/doi.org\/10.1007\/s40618-019-01079-6","journal-title":"J Endocrinol Invest"},{"issue":"1","key":"2668_CR4","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.eprac.2021.09.011","volume":"28","author":"LM Gruber","year":"2022","unstructured":"Gruber LM, Bancos I (2022) Secondary adrenal insufficiency: recent updates and new directions for diagnosis and management. Endocr Pract 28(1):110\u2013117. https:\/\/doi.org\/10.1016\/j.eprac.2021.09.011","journal-title":"Endocr Pract"},{"key":"2668_CR5","unstructured":"Huecker MR, Bhutta BS, Dominique E, Adrenal Insufficiency (2025) StatPearls. Treasure Island (FL) ineligible companies. Disclosure: Beenish Bhutta declares no relevant financial relationships with ineligible companies. Disclosure: Elvita Dominique declares no relevant financial relationships with ineligible companies.: StatPearls publishing copyright \u00a9 2025. StatPearls Publishing LLC."},{"key":"2668_CR6","doi-asserted-by":"publisher","first-page":"897211","DOI":"10.3389\/fendo.2022.897211","volume":"13","author":"CM Caetano","year":"2022","unstructured":"Caetano CM, Malchoff CD (2022) Daily glucocorticoid replacement dose in adrenal insufficiency, a mini review. Front Endocrinol (Lausanne) 13:897211. https:\/\/doi.org\/10.3389\/fendo.2022.897211","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"2668_CR7","doi-asserted-by":"publisher","first-page":"G25","DOI":"10.1093\/ejendo\/lvae029","volume":"190","author":"F Beuschlein","year":"2024","unstructured":"Beuschlein F, Else T, Bancos I et al (2024) European society of endocrinology and endocrine society joint clinical guideline: diagnosis and therapy of glucocorticoid-induced adrenal insufficiency. Eur J Endocrinol 190(5):G25\u2013G51. https:\/\/doi.org\/10.1093\/ejendo\/lvae029","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2668_CR8","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1365-2265.2005.02320.x","volume":"63","author":"A Crown","year":"2005","unstructured":"Crown A, Lightman S (2005) Why is the management of glucocorticoid deficiency still controversial: a review of the literature. Clin Endocrinol (Oxf) 63(5):483\u2013492. https:\/\/doi.org\/10.1111\/j.1365-2265.2005.02320.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"2","key":"2668_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1210\/jc.2014-3191","volume":"100","author":"S Hahner","year":"2015","unstructured":"Hahner S, Spinnler C, Fassnacht M et al (2015) High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study. J Clin Endocrinol Metab 100(2):407\u2013416. https:\/\/doi.org\/10.1210\/jc.2014-3191","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2668_CR10","doi-asserted-by":"publisher","first-page":"R231","DOI":"10.1530\/eje-17-0154","volume":"177","author":"G Mazziotti","year":"2017","unstructured":"Mazziotti G, Formenti AM, Frara S et al (2017) MANAGEMENT OF ENDOCRINE DISEASE: risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects. Eur J Endocrinol 177(5):R231\u2013r248. https:\/\/doi.org\/10.1530\/eje-17-0154","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2668_CR11","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1007\/s40618-020-01386-3","volume":"44","author":"S Puglisi","year":"2021","unstructured":"Puglisi S, Rossini A, Tabaro I et al (2021) What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study. J Endocrinol Invest 44(4):865\u2013872. https:\/\/doi.org\/10.1007\/s40618-020-01386-3","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"2668_CR12","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1210\/jc.2008-0125","volume":"93","author":"LK Nieman","year":"2008","unstructured":"Nieman LK, Biller BM, Findling JW et al (2008) The diagnosis of cushing\u2019s syndrome: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 93(5):1526\u20131540. https:\/\/doi.org\/10.1210\/jc.2008-0125","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2668_CR13","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1530\/eje-08-0874","volume":"160","author":"M Debono","year":"2009","unstructured":"Debono M, Ross RJ, Newell-Price J (2009) Inadequacies of glucocorticoid replacement and improvements by physiological circadian therapy. Eur J Endocrinol 160(5):719\u2013729. https:\/\/doi.org\/10.1530\/eje-08-0874","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"2668_CR14","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/0002-9343(81)90363-6","volume":"71","author":"Y Shoenfeld","year":"1981","unstructured":"Shoenfeld Y, Gurewich Y, Gallant LA, Pinkhas J (1981) Prednisone-induced leukocytosis. Influence of dosage, method and duration of administration on the degree of leukocytosis. Am J Med 71(5):773\u2013778. https:\/\/doi.org\/10.1016\/0002-9343(81)90363-6","journal-title":"Am J Med"},{"issue":"5","key":"2668_CR15","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1007\/s40618-025-02535-2","volume":"48","author":"H Masri-Iraqi","year":"2025","unstructured":"Masri-Iraqi H, Rudman Y, Shochat T et al (2025) Leukocytosis in cushing\u2019s syndrome persists post-surgical remission and could predict a lower remission prognosis in patients with cushing\u2019s disease. J Endocrinol Invest 48(5):1217\u20131224. https:\/\/doi.org\/10.1007\/s40618-025-02535-2","journal-title":"J Endocrinol Invest"},{"key":"2668_CR16","unstructured":"EuroQol Research Foundation (2019) EQ-5D-5L User Guide. Version 3.0. EuroQol Research Foundation: Rotterdam. https:\/\/euroqol.org\/wp-content\/uploads\/2023\/11\/EQ-5D-5LUserguide-23-07.pdf"},{"issue":"1","key":"2668_CR17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1093\/ageing\/afy169","volume":"48","author":"AJ Cruz-Jentoft","year":"2019","unstructured":"Cruz-Jentoft AJ, Bahat G, Bauer J et al (2019) Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing 48(1):16\u201331. https:\/\/doi.org\/10.1093\/ageing\/afy169","journal-title":"Age Ageing"},{"issue":"6","key":"2668_CR18","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1016\/j.clnu.2016.02.002","volume":"35","author":"G Bahat","year":"2016","unstructured":"Bahat G, Tufan A, Tufan F et al (2016) Cut-off points to identify sarcopenia according to European working group on sarcopenia in older people (EWGSOP) definition. Clin Nutr 35(6):1557\u20131563. https:\/\/doi.org\/10.1016\/j.clnu.2016.02.002","journal-title":"Clin Nutr"},{"issue":"Suppl 1","key":"2668_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/ep.18.s1.1","volume":"18","author":"PS Jellinger","year":"2012","unstructured":"Jellinger PS, Smith DA, Mehta AE et al (2012) American Association of Clinical Endocrinologists\u2019 Guidelines for Management of Dyslipidemia and Prevention of Atherosclerosis. Endocr Pract 18(Suppl 1):1\u201378. https:\/\/doi.org\/10.4158\/ep.18.s1.1","journal-title":"Endocr Pract"},{"issue":"5","key":"2668_CR20","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","volume":"23","author":"KG Alberti","year":"2006","unstructured":"Alberti KG, Zimmet P, Shaw J (2006) Metabolic syndrome\u2013a new world-wide definition. A consensus statement from the international diabetes federation. Diabet Med 23(5):469\u2013480. https:\/\/doi.org\/10.1111\/j.1464-5491.2006.01858.x","journal-title":"Diabet Med"},{"issue":"247","key":"2668_CR21","first-page":"1","volume":"11","author":"JG Hollowell","year":"2005","unstructured":"Hollowell JG, van Assendelft OW, Gunter EW et al (2005) Hematological and iron-related analytes\u2013reference data for persons aged 1 year and over: united states, 1988-94. Vital Health Stat 11(247):1\u2013156","journal-title":"Vital Health Stat"},{"issue":"12","key":"2668_CR22","doi-asserted-by":"publisher","first-page":"4849","DOI":"10.1210\/jc.2006-0076","volume":"91","author":"R Bergthorsdottir","year":"2006","unstructured":"Bergthorsdottir R, Leonsson-Zachrisson M, Od\u00e9n A, Johannsson G (2006) Premature mortality in patients with addison\u2019s disease: a population-based study. J Clin Endocrinol Metab 91(12):4849\u20134853. https:\/\/doi.org\/10.1210\/jc.2006-0076","journal-title":"J Clin Endocrinol Metab"},{"issue":"8710","key":"2668_CR23","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-o","volume":"336","author":"T Ros\u00e9n","year":"1990","unstructured":"Ros\u00e9n T, Bengtsson BA (1990) Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336(8710):285\u2013288. https:\/\/doi.org\/10.1016\/0140-6736(90)91812-o","journal-title":"Lancet"},{"issue":"9254","key":"2668_CR24","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/s0140-6736(00)04006-x","volume":"357","author":"JW Tomlinson","year":"2001","unstructured":"Tomlinson JW, Holden N, Hills RK et al (2001) Association between premature mortality and hypopituitarism. West Midlands prospective hypopituitary study group. Lancet 357(9254):425\u2013431. https:\/\/doi.org\/10.1016\/s0140-6736(00)04006-x","journal-title":"Lancet"},{"issue":"11","key":"2668_CR25","doi-asserted-by":"publisher","first-page":"4216","DOI":"10.1210\/jc.2009-1097","volume":"94","author":"M Sherlock","year":"2009","unstructured":"Sherlock M, Reulen RC, Alonso AA et al (2009) ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly. J Clin Endocrinol Metab 94(11):4216\u20134223. https:\/\/doi.org\/10.1210\/jc.2009-1097","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"2668_CR26","doi-asserted-by":"publisher","first-page":"3912","DOI":"10.1210\/jc.2007-0685","volume":"92","author":"S Hahner","year":"2007","unstructured":"Hahner S, Loeffler M, Fassnacht M et al (2007) Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross-sectional analysis. J Clin Endocrinol Metab 92(10):3912\u20133922. https:\/\/doi.org\/10.1210\/jc.2007-0685","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"2668_CR27","doi-asserted-by":"publisher","first-page":"207","DOI":"10.7326\/0003-4819-120-3-199402010-00005","volume":"120","author":"PM Zelissen","year":"1994","unstructured":"Zelissen PM, Croughs RJ, van Rijk PP, Raymakers JA (1994) Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease. Ann Intern Med 120(3):207\u2013210. https:\/\/doi.org\/10.7326\/0003-4819-120-3-199402010-00005","journal-title":"Ann Intern Med"},{"issue":"10","key":"2668_CR28","doi-asserted-by":"publisher","first-page":"3954","DOI":"10.1210\/jc.2006-0524","volume":"91","author":"H Filipsson","year":"2006","unstructured":"Filipsson H, Monson JP, Koltowska-H\u00e4ggstr\u00f6m M, Mattsson A, Johannsson G (2006) The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients. J Clin Endocrinol Metab 91(10):3954\u20133961. https:\/\/doi.org\/10.1210\/jc.2006-0524","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"2668_CR29","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1046\/j.1365-2265.2002.01466.x","volume":"56","author":"K L\u00f8v\u00e5s","year":"2002","unstructured":"L\u00f8v\u00e5s K, Loge JH, Husebye ES (2002) Subjective health status in Norwegian patients with addison\u2019s disease. Clin Endocrinol (Oxf) 56(5):581\u2013588. https:\/\/doi.org\/10.1046\/j.1365-2265.2002.01466.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2668_CR30","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1111\/j.1365-2265.2006.02473.x","volume":"64","author":"W Arlt","year":"2006","unstructured":"Arlt W, Rosenthal C, Hahner S, Allolio B (2006) Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements. Clin Endocrinol (Oxf) 64(4):384\u2013389. https:\/\/doi.org\/10.1111\/j.1365-2265.2006.02473.x","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2668_CR31","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/cen.12316","volume":"80","author":"M Whitaker","year":"2014","unstructured":"Whitaker M, Debono M, Huatan H et al (2014) An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure. Clin Endocrinol (Oxf) 80(4):554\u2013561. https:\/\/doi.org\/10.1111\/cen.12316","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"1","key":"2668_CR32","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1530\/eje-09-0170","volume":"161","author":"G Johannsson","year":"2009","unstructured":"Johannsson G, Bergthorsdottir R, Nilsson AG et al (2009) Improving glucocorticoid replacement therapy using a novel modified-release hydrocortisone tablet: a Pharmacokinetic study. Eur J Endocrinol 161(1):119\u2013130. https:\/\/doi.org\/10.1530\/eje-09-0170","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2668_CR33","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s12020-021-02649-6","volume":"71","author":"H Nowotny","year":"2021","unstructured":"Nowotny H, Ahmed SF, Bensing S et al (2021) Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis. Endocrine 71(3):586\u2013594. https:\/\/doi.org\/10.1007\/s12020-021-02649-6","journal-title":"Endocrine"},{"issue":"2","key":"2668_CR34","doi-asserted-by":"publisher","first-page":"155","DOI":"10.26650\/IUITFD.1626109","volume":"88","author":"MF Burak","year":"2025","unstructured":"Burak MF, \u00c7etin E (2025) Latest advances for treating congenital adrenal hyperplasia due to 21-hydroxylase deficiency. J Istanbul Fac Med 88(2):155\u2013163. https:\/\/doi.org\/10.26650\/IUITFD.1626109","journal-title":"J Istanbul Fac Med"},{"issue":"6","key":"2668_CR35","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1056\/NEJMoa2404656","volume":"391","author":"RJ Auchus","year":"2024","unstructured":"Auchus RJ, Hamidi O, Pivonello R et al (2024) Phase 3 trial of Crinecerfont in adult congenital adrenal hyperplasia. N Engl J Med 391(6):504\u2013514. https:\/\/doi.org\/10.1056\/NEJMoa2404656","journal-title":"N Engl J Med"},{"key":"2668_CR36","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/BF03345709","volume":"32","author":"C Erem","year":"2009","unstructured":"Erem C, Nuhoglu I, Yilmaz M et al (2009) Blood coagulation and fibrinolysis in patients with cushing\u2019s syndrome: increased plasminogen activator inhibitor-1, decreased tissue factor pathway inhibitor, and unchanged thrombin-activatable fibrinolysis inhibitor levels. J Endocrinol Invest 32:169\u2013174","journal-title":"J Endocrinol Invest"},{"issue":"2","key":"2668_CR37","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/(SICI)1096-8652(199910)62:2<65::AID-AJH1>3.0.CO;2-G","volume":"62","author":"S Grafte-Faure","year":"1999","unstructured":"Grafte-Faure S, Leveque C, Vasse M et al (1999) Effects of glucocorticoids and mineralocorticoids on proliferation and maturation of human peripheral blood stem cells. Am J Hematol 62(2):65\u201373. https:\/\/doi.org\/10.1002\/(sici)1096-8652(199910)62:2%3C65::aid-ajh1%3E3.0.co;2-g","journal-title":"Am J Hematol"},{"issue":"8","key":"2668_CR38","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1007\/bf03344186","volume":"29","author":"A Gursoy","year":"2006","unstructured":"Gursoy A, Dogruk Unal A, Ayturk S et al (2006) Polycythemia as the first manifestation of cushing\u2019s disease. J Endocrinol Invest 29(8):742\u2013744. https:\/\/doi.org\/10.1007\/bf03344186","journal-title":"J Endocrinol Invest"},{"issue":"21","key":"2668_CR39","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1161\/01.cir.98.21.2307","volume":"98","author":"M Nakagawa","year":"1998","unstructured":"Nakagawa M, Terashima T, D\u2019Yachkova Y et al (1998) Glucocorticoid-induced granulocytosis: contribution of marrow release and demargination of intravascular granulocytes. Circulation 98(21):2307\u20132313. https:\/\/doi.org\/10.1161\/01.cir.98.21.2307","journal-title":"Circulation"},{"issue":"5","key":"2668_CR40","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1530\/EJE-10-0583","volume":"163","author":"L Manetti","year":"2010","unstructured":"Manetti L, Bogazzi F, Giovannetti C et al (2010) Changes in coagulation indexes and occurrence of venous thromboembolism in patients with cushing\u2019s syndrome: results from a prospective study before and after surgery. Eur J Endocrinol 163(5):783\u2013791","journal-title":"Eur J Endocrinol"},{"key":"2668_CR41","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.plefa.2018.11.004","volume":"139","author":"A Barden","year":"2018","unstructured":"Barden A, Phillips M, Hill LM et al (2018) Antiemetic doses of dexamethasone and their effects on immune cell populations and plasma mediators of inflammation resolution in healthy volunteers. Prostaglandins Leukot Essent Fat Acids 139:31\u201339. https:\/\/doi.org\/10.1016\/j.plefa.2018.11.004","journal-title":"Prostaglandins Leukot Essent Fat Acids"},{"issue":"21","key":"2668_CR42","doi-asserted-by":"publisher","first-page":"7187","DOI":"10.12998\/wjcc.v10.i21.7187","volume":"10","author":"WY Jia","year":"2022","unstructured":"Jia WY, Zhang JJ (2022) Effects of glucocorticoids on leukocytes: genomic and non-genomic mechanisms. World J Clin Cases 10(21):7187\u20137194. https:\/\/doi.org\/10.12998\/wjcc.v10.i21.7187","journal-title":"World J Clin Cases"},{"issue":"2","key":"2668_CR43","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1182\/blood.V94.2.550","volume":"94","author":"M von Lindern","year":"1999","unstructured":"von Lindern M, Zauner W, Mellitzer G et al (1999) The glucocorticoid receptor cooperates with the erythropoietin receptor and c-Kit to enhance and sustain proliferation of erythroid progenitors in vitro. Blood 94(2):550\u2013559","journal-title":"Blood"},{"issue":"4","key":"2668_CR44","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.3324\/haematol.2021.280542","volume":"108","author":"L Varricchio","year":"2023","unstructured":"Varricchio L, Geer EB, Martelli F et al (2023) Patients with hypercortisolemic Cushing disease possess a distinct class of hematopoietic progenitor cells leading to erythrocytosis. Haematologica 108(4):1053\u20131067. https:\/\/doi.org\/10.3324\/haematol.2021.280542","journal-title":"Haematologica"},{"issue":"8","key":"2668_CR45","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.3390\/ani13081299","volume":"13","author":"S Kim","year":"2023","unstructured":"Kim S, Chaudhary PK, Kim S (2023) Role of prednisolone in platelet activation by inhibiting TxA2 generation through the regulation of cPLA2 phosphorylation. Animals 13(8):1299","journal-title":"Animals"},{"issue":"1","key":"2668_CR46","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s40618-022-01892-6","volume":"46","author":"M Paja","year":"2023","unstructured":"Paja M, Merlo I, Rodr\u00edguez-Soto J et al (2023) White blood cell count: a valuable tool for suspecting cushing\u2019s syndrome. J Endocrinol Invest 46(1):141\u2013149. https:\/\/doi.org\/10.1007\/s40618-022-01892-6","journal-title":"J Endocrinol Invest"},{"issue":"5","key":"2668_CR47","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1007\/s11102-013-0522-0","volume":"17","author":"H Masri-Iraqi","year":"2014","unstructured":"Masri-Iraqi H, Robenshtok E, Tzvetov G, Manistersky Y, Shimon I (2014) Elevated white blood cell counts in cushing\u2019s disease: association with hypercortisolism. Pituitary 17(5):436\u2013440. https:\/\/doi.org\/10.1007\/s11102-013-0522-0","journal-title":"Pituitary"},{"issue":"6b","key":"2668_CR48","doi-asserted-by":"publisher","first-page":"4s","DOI":"10.1016\/s0002-9610(02)01172-8","volume":"184","author":"PE O'Brien","year":"2002","unstructured":"O\u2019Brien PE, Dixon JB (2002) The extent of the problem of obesity. Am J Surg 184(6b):4s\u20138s. https:\/\/doi.org\/10.1016\/s0002-9610(02)01172-8","journal-title":"Am J Surg"},{"issue":"1","key":"2668_CR49","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/s1098-3597(08)60024-1","volume":"9","author":"CP Cannon","year":"2008","unstructured":"Cannon CP (2008) Obesity-related cardiometabolic complications. Clin Cornerstone 9(1):11\u201319 discussion 20\u2013\u200912. https:\/\/doi.org\/10.1016\/s1098-3597(08)60024-1","journal-title":"Clin Cornerstone"},{"issue":"6","key":"2668_CR50","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1111\/j.1600-0609.2006.00658.x","volume":"76","author":"Y Herishanu","year":"2006","unstructured":"Herishanu Y, Rogowski O, Polliack A, Marilus R (2006) Leukocytosis in obese individuals: possible link in patients with unexplained persistent neutrophilia. Eur J Haematol 76(6):516\u2013520. https:\/\/doi.org\/10.1111\/j.1600-0609.2006.00658.x","journal-title":"Eur J Haematol"},{"issue":"5","key":"2668_CR51","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1111\/cen.14568","volume":"95","author":"L Martel-Duguech","year":"2021","unstructured":"Martel-Duguech L, Alonso-Jimenez A, Bascu\u00f1ana H et al (2021) Prevalence of sarcopenia after remission of hypercortisolism and its impact on HRQoL. Clin Endocrinol (Oxf) 95(5):735\u2013743. https:\/\/doi.org\/10.1111\/cen.14568","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"2668_CR52","doi-asserted-by":"publisher","first-page":"e1477","DOI":"10.1210\/clinem\/dgab862","volume":"107","author":"S Katsuhara","year":"2022","unstructured":"Katsuhara S, Yokomoto-Umakoshi M, Umakoshi H et al (2022) Impact of cortisol on reduction in muscle strength and mass: A Mendelian randomization study. J Clin Endocrinol Metab 107(4):e1477\u2013e1487. https:\/\/doi.org\/10.1210\/clinem\/dgab862","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02668-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40618-025-02668-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40618-025-02668-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T17:05:43Z","timestamp":1762880743000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40618-025-02668-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,19]]},"references-count":52,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["2668"],"URL":"https:\/\/doi.org\/10.1007\/s40618-025-02668-4","relation":{},"ISSN":["1720-8386"],"issn-type":[{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,19]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed following the Declaration of Helsinki recommendations, and the Clinical Ethics Committee of the Istanbul Faculty of Medicine approved the study. All patients and the controls were informed about the study, and informed consent was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors have no competing interests to declare relevant to this article\u2019s content. Each author confirms that this manuscript has been prepared and sent with his\/her approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}